Kennedy Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,978
| Closed | -$189K | – | 761 |
|
|
2024
Q1 | $189K | Buy |
+11,978
| New | +$189K | ﹤0.01% | 709 |
|
|
2023
Q4 | – | Sell |
-156,475
| Closed | -$3.14M | – | 724 |
|
|
2023
Q3 | $3.14M | Buy |
156,475
+4,178
| +3% | +$83.8K | 0.08% | 377 |
|
|
2023
Q2 | $4.3M | Sell |
152,297
-96,143
| -39% | -$2.71M | 0.1% | 324 |
|
|
2023
Q1 | $4.27M | Buy |
248,440
+13,833
| +6% | +$238K | 0.13% | 286 |
|
|
2022
Q4 | $4.72M | Sell |
234,607
-8,396
| -3% | -$169K | 0.13% | 282 |
|
|
2022
Q3 | $5.26M | Buy |
243,003
+121,408
| +100% | +$2.63M | 0.15% | 233 |
|
|
2022
Q2 | $3.42M | Buy |
+121,595
| New | +$3.42M | 0.1% | 343 |
|